Medicalization: Current concept and future directions in a Bionic Society

Mens Sana Monographs

Volumn 10, Issue 1, 2012, Pages 122-133

  Maturo, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biomedicalization; Bionic society; Human enhancement; Medicalization; Pharmaceuticalization; Risk

Indexed keywords

EID: 84861304206     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.91587     Document Type: Article

References (34)

1. Abraham J. The Sociological Concomitants of the Pharmaceutical Industry and Medications. In: C. Bird, P. Conrad, A. Fremont, S. Timmermans (Eds.), Handbook of Medical Sociology (p. 290-308). Nashville: Vanderbilt U.P; 2010.
2. Angell M. The truth about the drug companies. London: Random House; 1988.
3. Barker K. Medicalization, multiplication of diseases, and human enhancement. Salute e Società 2009;8:99-122.
4. Barker K. Electronic support group, patient-consumers, and medicalization: The case of contested illness. J Health Soc Behav 2008;49:20-36. PMID: 18418983
5. Cipolla C. Why we cannot consider ourselves Darwinists anymore (Why Dunant won over Darwin). Salute e Società 2010;9:138-42.
6. Clarke A., Shim J. Medicalization and Biomedicalization Revisited: Technoscience and Transformations of Health, Illness, and Biomedicine. In: B. A. Pescosolido et al. (Eds.), Handbook of the Sociology of Health, Illness, and Healing (p173-200). New York: Springer; 2011.
7. Conrad P. The Shifting Engines of Medicalization. Salute e Società 2009;8:31-48.
8. Conrad P. The Medicalization of Society: On the Transformation of Human Conditions into Treatable Disorders. Baltimore, MD: Johns Hopkins University Press; 2007.
9. Douglas M. Risk and Blame. London: Routledge; 1992.
10. Foucault M. Crisis de un modelo en la medicina?. Revista centroamericana de Ciencias de la Salud 1976;3:202-19.
11. Freidson, E. Profession of Medicine, New York: Dodd, Mead; 1970.
12. Fulford KW. Neuroscience and values: A case study illustrating developments in policy, training and research in the UK and internationally. Mens Sana Monographs 2010;9:79-92.
13. Horwitz A. Pharmaceuticals and the Medicalization of Social Life. In: D. Light (Ed.), The Risks of Prescription Drugs. New York: Columbia U.P.; 2010. p. 92-115
14. Horwitz A. Creating Mental Illness. Chicago: University of Chicago U.P.; 2002.
15. Horwitz A., Wakefield J. The Medicalization of Sadness. Salute e Società 2009;8:49-66.
16. Horwitz A.V., Wakefield J. The Loss of Sadness. How Psychiatry Transformed Normal Sorrow Into Depressive Disorder, New York: Oxford University Press; 2007.
17. Illich I. Limits to Medicine-Medical Nemesis: The Expropriation of Health. London: Marion Boyars Publisher Ltd.; 1973.
18. Jutel A. Sociology of diagnosis: A preliminary review. Soc Health Illness 2009;31:278-99
19. Light D. Bearing the Risks of Prescription Drugs. In: D. Light (Ed.) The Risks of Prescription Drugs. New York: Columbia U.P.; 2010. p. 40-69.
20. Link B, Phelan J. Social Conditions as Fundamental Causes of Health Inequalities. In: C. Bird, P. Conrad, A. Fremont, S. Timmermans (Eds.), Handbook of Medical Sociology. Nashville: Vanderbilt U.P; 2010. p. 3-17.
21. Luhmann N. Risk: A Sociological Theory. Berlin: De Gruyter; 1993.
22. Maturo A. Bipolar Disorder and the Medicalization of Mood: An Epidemics of Diagnosis? In: A. Mukherjea (Ed.). Understanding Emerging Epidemics: Social and Political Approaches. London: Emerald; 2010a. p. 225-42.
23. Maturo A. Towards a bionic society? Salute e Società 2010b;9:215-20.
24. Maturo A. Shifting borders of medicalization: Perspectives and dilemmas of human enhancement. Salute e Società 2009a;8:13-31.
25. Maturo A. Médicalisation, marketing pharmaceutique et inégalité sociales. Revue Sociologie Santé 2009b;30:177-86.
26. Moynihan R, Cassels A. Selling sickness. How drug companies are turning us into patients. New York: Nation Books; 2005.
27. Murray J. Direct-to-consumer prescription drug advertising in a global context: A comparison between New Zealand and the US. Salute e Società 2009a;8:189-201.
28. Rose N. The Politics of Life, Princeton: Princeton University Press; 2006.
29. Scott J, Dikey B. Global burden of depression: The intersection of culture and medicine. Br J Psychiatry 2003;183:92-4. PMID: 12893658 (Pubitemid 36963130)
30. Shostak S, Frese J. Gene-Environment Interaction and Medical Sociology. In: C. Bird, P. Conrad, A. Fremont, S. Timmermans (Eds.), Handbook of Medical Sociology. Nashville: Vanderbilt U.P; 2010. p. 418-34.
31. Smith DJ, Ghaemi SN, Craddock N. The broad clinical spectrum of bipolar disorder: Implications for research and practice. J Psychopharmacol 2008;22:397-400. (Pubitemid 351989985)
32. Turner B. The New Medical Sociology. London: Norton & Company; 2004.
33. World Health Organization. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference: New York, 19-22 June 1946.
34. Zola I.K. Socio-Medical Inquires. Philadelphia: Temple U.P.; 1982.